Figure 3.

The number of IL-13⁺ and Gr1/Ly6G⁺ leukocytes in mesenteric lymph nodes and tumor tissue increases in azoxymethane-treated RELMβ^−/− FVB mice. A: Colon mRNA expression. Percentage of interferon (IFN)γ⁺, IL13⁺, CD4-Gr1⁺, and CD4⁺Gr1⁻ cells of total living leukocytes in mesenteric lymph node (B–D) and colon tumors (C–E). N = 10 per genotype (A); N = 4 wild type and knockout (B–E). ^∗P < 0.05, ^∗∗P < 0.01 for the difference between the genotypes. L.N., lymph node; WT, wild type.